A grading system to evaluate objectively the strength of pre-clinical data of acute neuroprotective therapies for clinical translation in spinal cord injury.
about
Biomaterial-based interventions for neuronal regeneration and functional recovery in rodent model of spinal cord injury: a systematic reviewRestoration of sensorimotor functions after spinal cord injuryTranslational spinal cord injury research: preclinical guidelines and challengesDrug delivery, cell-based therapies, and tissue engineering approaches for spinal cord injuryMinimum information about a spinal cord injury experiment: a proposed reporting standard for spinal cord injury experimentsSyndromics: a bioinformatics approach for neurotrauma researchFacilitating transparency in spinal cord injury studies using data standards and ontologies.Efficacy of a metalloproteinase inhibitor in spinal cord injured dogs.Publication bias in animal research presented at the 2008 Society of Critical Care Medicine ConferenceTreatment of rat spinal cord injury with the neurotrophic factor albumin-oleic acid: translational application for paralysis, spasticity and pain.Clinical and experimental advances in regeneration of spinal cord injury.Naturally occurring disk herniation in dogs: an opportunity for pre-clinical spinal cord injury researchEvaluation of spinal cord injury animal models.Anti-CD11d monoclonal antibody treatment for rat spinal cord compression injury.Intermittent fasting improves functional recovery after rat thoracic contusion spinal cord injury.Are you "tilting at windmills" or undertaking a valid clinical trial?Leveraging biomedical informatics for assessing plasticity and repair in primate spinal cord injury.Delayed Imatinib Treatment for Acute Spinal Cord Injury: Functional Recovery and Serum BiomarkersSpinal cord injury - there is not just one way of treating it.Investigational drugs for the treatment of spinal cord injury: review of preclinical studies and evaluation of clinical trials from Phase I to II.Developing a spinal cord injury research strategy using a structured process of evidence review and stakeholder dialogue. Part III: outcomes.Developing a spinal cord injury research strategy using a structured process of evidence review and stakeholder dialogue. Part II: Background to a research strategy.Developing a spinal cord injury research strategy using a structured process of evidence review and stakeholder dialogue. Part I: rapid review of SCI prioritisation literature.Preclinical models of muscle spasticity: valuable tools in the development of novel treatment for neurological diseases and conditions.Olfactory Ensheathing Cell Transplantation in Experimental Spinal Cord Injury: Effect size and Reporting Bias of 62 Experimental Treatments: A Systematic Review and Meta-Analysis.Neural precursor cell transplantation enhances functional recovery and reduces astrogliosis in bilateral compressive/contusive cervical spinal cord injury.A contusion model of severe spinal cord injury in rats.Cellular neuroinflammation in a lateral forceps compression model of spinal cord injury.iPSC-derived neural precursor cells: potential for cell transplantation therapy in spinal cord injury.Human Spinal Oligodendrogenic Neural Progenitor Cells Promote Functional Recovery After Spinal Cord Injury by Axonal Remyelination and Tissue Sparing
P2860
Q26998135-F495FD64-8E7A-43C8-A522-F35E0D2B8B40Q26999051-D69289BE-03D7-4A94-BC6D-3724E49C9D80Q27025285-5D5FD107-45AE-4DAA-8E4F-D6DF5A725DDDQ28085174-B7479D09-C39D-46AD-820C-8B0FA7EF99ABQ28654987-6378A35D-055B-420A-B9B3-56491DB65F38Q28741573-17250929-C633-4664-8722-3F7A9572CA98Q30849646-DD865C3E-A0F7-4697-83B0-FC918B0F12D7Q33553427-55BC95CB-F5E7-4D11-915F-AEA05EAAC03CQ33883394-C71AB51B-622F-4F78-B120-AC3008550561Q34064354-4DE5A192-3E80-4196-A708-449665E164B8Q34591366-560B321C-3BB9-4A10-9B93-8588B3988F4EQ34757608-1D4D043F-78CF-4C52-9F77-BACE0FDEAC24Q34813971-6B4F27C7-606B-455E-ADE0-D9C989AE3320Q34827203-B315165D-2CF9-40B2-B9BA-11A3B2B57748Q35057728-51154428-A99B-4C13-9286-FD1745E1D82DQ35176265-0CF37440-4B06-4CEB-A6F2-08814DF26F45Q35567343-146BE04B-5CEA-46A6-850E-A36D743123CDQ36576063-4AE61BB7-3C55-4844-9C34-BF128E3E4B6DQ38262509-3E787008-0C65-4546-96C3-40F058A0A792Q38342072-0CC7EF7E-14A0-48B7-999F-18E38045DE2FQ38388999-3E17B042-C6CF-4092-AF9A-DE9BC374DA3AQ38534358-DF93CDB2-DB56-4A57-954A-F388B12E7E73Q38534362-6F5C7F93-3F35-4808-A318-6042205FB3B5Q38727855-660425BA-13F2-4E48-A0FE-ED73276C92DAQ38849057-8DC678DD-5F12-45D7-9DB4-F8B6D7E4A02BQ41905129-B3218214-41D7-43FD-B727-230858E041F3Q42038193-20F423BA-3D91-4BC3-A28B-922AA78B6BD3Q44014570-2CD4A307-AE60-4DCE-AD30-690E51F075DDQ47906823-6C3018D8-E3B5-44EC-B8B9-0AFDEA5460D9Q57838190-44F561AB-4080-4663-8FD7-5241D7CEB3C5
P2860
A grading system to evaluate objectively the strength of pre-clinical data of acute neuroprotective therapies for clinical translation in spinal cord injury.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
A grading system to evaluate o ...... slation in spinal cord injury.
@ast
A grading system to evaluate o ...... slation in spinal cord injury.
@en
type
label
A grading system to evaluate o ...... slation in spinal cord injury.
@ast
A grading system to evaluate o ...... slation in spinal cord injury.
@en
prefLabel
A grading system to evaluate o ...... slation in spinal cord injury.
@ast
A grading system to evaluate o ...... slation in spinal cord injury.
@en
P2093
P2860
P50
P356
P1476
A grading system to evaluate o ...... nslation in spinal cord injury
@en
P2093
Andrew R Blight
Brian K Kwon
Dana M McTigue
James D Guest
Lynne C Weaver
Martin Oudega
Michael S Beattie
Paul J Reier
Phillip G Popovich
Wolfram Tetzlaff
P2860
P304
P356
10.1089/NEU.2010.1296
P577
2010-10-18T00:00:00Z